Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride in low-risk prostate cancer (MAPPED)
NCT01193855Phase 2Unknown
- Sponsor
- UCLH
- Start
- Jun 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dutasteride in prostate cancer (PCa), sponsored by UCLH. Status: unknown.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01193855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193855.